Harnessing prions as test agents for the development of broad-range disinfectants

Prion

Volumn 6, Issue 1, 2012, Pages 1-6

  Wagenführ, Katja ^a   Beekes, Michael ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Cell assay; Disinfection; Prion; Prion protein; Protein misfolding cyclic amplification; Scrapie; Seeding activity; Surgical instruments; Transmissible spongiform encephalopathies

Indexed keywords

DISINFECTANT AGENT; PRION PROTEIN;

BIOASSAY; CELL ASSAY; CHEMICAL ANALYSIS; DISINFECTION; IN VITRO STUDY; NONHUMAN; PILOT STUDY; POLYMERIZATION; QUANTITATIVE ANALYSIS; REVIEW; VALIDATION PROCESS;

BACTERIA; DISINFECTANTS; DISINFECTION; FUNGI; HUMANS; PRIONS; SURGICAL INSTRUMENTS;

EID: 84857210475     PISSN: 19336896     EISSN: 1933690X     Source Type: Journal    
DOI: 10.4161/pri.6.1.18556     Document Type: Review

References (55)

1. McDonnell G, Burke P. Disinfection: is it time to reconsider Spaulding? J Hosp Infect 2011; 78:163-70; PMID:21664533; http://dx.doi.org/10.1016/j.jhin. 2011.05.002.
2. Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136-44; PMID:6801762; http://dx.doi.org/10.1126/science. 6801762.
3. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363.
4. Brown P, Cervenakova L. A prion lexicon (out of control). Lancet 2005; 365:122; PMID:15639292; http://dx.doi.org/10.1016/S0140-6736(05)17700-9.
5. Come JH, Fraser PE, Lansbury PT Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90:5959-63; PMID:8327467; http://dx.doi.org/10.1073/pnas.90.13.5959.
6. Soto C. Prion hypothesis: the end of the controversy? Trends Biochem Sci 2011; 36:151-8; PMID:21130657; http://dx.doi.org/10.1016/j.tibs.2010.11.001.
7. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977; 1:478-9; PMID:65575; http://dx.doi.org/10.1016/S0140-6736(77)91958-4.
8. Gibbs CJ Jr, Asher DM, Kobrine A, Amyx HL, Sulima MP, Gajdusek DC. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J Neurol Neurosurg Psychiatry 1994; 57:757-8; PMID:8006664; http://dx.doi.org/10.1136/jnnp.57.6.757.
9. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000; 55:1075-81; PMID:11071481.
10. Kondo K, Kuroiwa Y. A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982; 11:377-81; PMID:7049055; http://dx.doi.org/10.1002/ana.410110410.
11. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999; 353:693-7; PMID:10073510; http://dx.doi.org/10.1016/S0140-6736(98) 08138-0.
12. Ward HJ, Everington D, Croes EA, Alperovitch A, Delasnerie- Lauprêtre N, Zerr I, et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002; 59:543-8; PMID:12196646.
13. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, et al. Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006; 59:111-20; PMID:16287153; http://dx.doi.org/10.1002/ana.20708.
14. de Pedro-Cuesta J, Mahillo-Fernández I, Rábano A, Calero M, Cruz M, Siden A. EUROSURGYCJD Research Group. Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry 2011; 82:204-12; PMID:20547628; http://dx.doi.org/10.1136/jnnp.2009.188425.
15. Lehmann S, Pastore M, Rogez-Kreuz C, Richard M, Belondrade M, Rauwel G, et al. New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive medical equipment. J Hosp Infect 2009; 72:342-50; PMID:19541387; http://dx.doi.org/10.1016/j.jhin.2009.03. 024.
16. Beekes M, Lemmer K, Thomzig A, Joncic M, Tintelnot K, Mielke M. Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol 2010; 91:580-9; PMID:19864502; http://dx.doi.org/10.1099/vir.0.016337-0.
17. Brown P, Rohwer RG, Gajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986; 153:1145-8; PMID:3084671; http://dx.doi.org/10.1093/infdis/153.6.1145.
18. Taylor DM. Inactivation of SE agents. Br Med Bull 1993; 49:810-21; PMID:8137130.
19. Beekes M, McBride PA. The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 2007; 274:588-605; http://dx.doi.org/10.1111/j.1742-4658.2007.05631.x.
20. Sc bound to steel surfaces. J Gen Virol 2004; 85:3805-16; PMID:15557254; http://dx.doi.org/10.1099/vir.0. 80346-0.
21. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C. Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 1999; 5:240-3; PMID:10448646.
22. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001; 7:679-84; PMID:11713367.
23. Fichet G, Comoy E, Duval C, Antloga K, Dehen C, Charbonnier A, et al. Novel methods for disinfection of prion-contaminated medical devices. Lancet 2004; 364:521-6; PMID:15302195; http://dx.doi.org/10.1016/S0140-6736(04)16810-4.
24. Fichet G, Comoy E, Dehen C, Challier L, Antloga K, Deslys JP, et al. Investigations of a prion infectivity assay to evaluate methods of decontamination. J Microbiol Methods 2007; 70:511-8; PMID:17640752; http://dx.doi.org/10.1016/j.mimet.2007.06.005.
25. Klöhn PC, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 2003; 100:11666-71; PMID:14504404; http://dx.doi.org/10.1073/pnas.1834432100.
26. Mahal SP, Demczyk CA, Smith EW Jr, Klöhn PC, Weissmann C. Assaying prions in cell culture: the standard scrapie cell assay (SSCA) and the scrapie cell assay in end point format (SCEPA). Methods Mol Biol 2008; 459:49-68; PMID:18576147; http://dx.doi.org/10.1007/978-1-59745-234-2-4.
27. Edgeworth JA, Jackson GS, Clarke AR, Weissmann C, Collinge J. Highly sensitive, quantitative cell-based assay for prions adsorbed to solid surfaces. Proc Natl Acad Sci USA 2009; 106:3479-83; PMID:19204279; http://dx.doi.org/10. 1073/pnas.0813342106.
28. Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810-3; PMID:11459061; http://dx.doi.org/10.1038/35081095.
29. Castilla J, Saá P, Morales R, Abid K, Maundrell K, Soto C. Protein misfolding cyclic amplification for diagnosis and prion propagation studies. Methods Enzymol 2006; 412:3-21; PMID:17046648; http://dx.doi.org/10.1016/S0076- 6879(06)12001-7.
30. Chen B, Morales R, Barria MA, Soto C. Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat Methods 2010; 7:519-20; PMID:20512142; http://dx.doi.org/10.1038/nmeth.1465.
31. Wilham JM, Orrú CD, Bessen RA, Atarashi R, Sano K, Race B, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 2010; 6:1001217; PMID:21152012; http://dx.doi.org/10.1371/journal.ppat.1001217.
32. Murayama Y, Yoshioka M, Horii H, Takata M, Yokoyama T, Sudo T, et al. Protein misfolding cyclic amplification as a rapid test for assessment of prion inactivation. Biochem Biophys Res Commun 2006; 348:758-62; PMID:16890914; http://dx.doi.org/10.1016/j.bbrc.2006.07.130.
33. Pritzkow S, Wagenführ K, Daus ML, Boerner S, Lemmer K, Thomzig A, et al. Quantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfection. PLoS One 2011; 6:20384; PMID:21647368; http://dx.doi.org/10.1371/journal. pone.0020384.
34. Takeuchi A, Komiya M, Kitamoto T, Morita M. Deduction of the evaluation limit and termination timing of multi-round protein misfolding cyclic amplification from a titration curve. Microbiol Immunol 2011; 55:502-9; PMID:21443616; http://dx.doi.org/10.1111/j.1348-0421.2011.00340.x.
35. Bieschke J, Weber P, Sarafoff N, Beekes M, Giese A, Kretzschmar H. Autocatalytic self-propagation of misfolded prion protein. Proc Natl Acad Sci USA 2004; 101:12207-11; PMID:15297610; http://dx.doi.org/10.1073/pnas. 0404650101.
36. Weber P, Giese A, Piening N, Mitteregger G, Thomzig A, Beekes M, et al. Cell-free formation of misfolded prion protein with authentic prion infectivity. Proc Natl Acad Sci USA 2006; 103:15818-23; PMID:17030802; http://dx.doi.org/10. 1073/pnas.0605608103.
37. Gonzalez-Montalban N, Makarava N, Ostapchenko VG, Savtchenk R, Alexeeva I, Rohwer RG, et al. Highly efficient protein misfolding cyclic amplification. PLoS Pathog 2011; 7:1001277; PMID:21347353; http://dx.doi.org/10.1371/journal. ppat.1001277.
38. Lemmer K, Mielke M, Kratzel C, Joncic M, Oezel M, Pauli G, et al. Decontamination of surgical instruments from prions. II. In vivo findings with a model system for testing the removal of scrapie infectivity from steel surfaces. J Gen Virol 2008; 89:348-58; PMID:18089760; http://dx.doi.org/10.1099/ vir.0.83396-0.
39. Somerville RA, Oberthur RC, Havekost U, MacDonald F, Taylor DM, Dickinson AG. Characterization of thermodynamic diversity between transmissible spongiform encephalopathy agent strains and its theoretical implications. J Biol Chem 2002; 277:11084-9; PMID:11792707; http://dx.doi.org/10.1074/jbc. M111766200.
40. Peretz D, Supattapone S, Giles K, Vergara J, Freyman Y, Lessard P, et al. Inactivation of prions by acidic sodium dodecyl sulfate. J Virol 2006; 80:322-31; PMID:16352557; http://dx.doi.org/10.1128/JVI.80.1.322-31.2006.
41. Giles K, Glidden DV, Beckwith R, Seoanes R, Peretz D, DeArmond SJ, et al. Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog 2008; 4:1000206; PMID:19008948; http://dx.doi.org/10.1371/journal. ppat.1000206.
42. Lawson VA, Stewart JD, Masters CL. Enzymatic detergent treatment protocol that reduces protease-resistant prion protein load and infectivity from surgical-steel monofilaments contaminated with a human-derived prion strain. J Gen Virol 2007; 88:2905-14; PMID:17872546; http://dx.doi.org/10.1099/vir.0. 82961-0.
43. Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, et al. Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance. Brain 2007; 130:1350-9; PMID:17472986; http://dx.doi.org/10.1093/brain/awm063.
44. Moreno-Gonzalez I, Soto C. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. Semin Cell Dev Biol 2011; 22:482-7; PMID:21571086; http://dx.doi.org/10.1016/j.semcdb.2011.04.002.
45. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994; 35:513-29; PMID:8179297; http://dx.doi.org/10.1002/ana.410350504.
46. Baker HF, Ridley RM, Duchen LW, Crow TJ, Bruton CJ. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 1994; 8:25-39; PMID:8086126; http://dx.doi.org/10.1007/BF02778005.
47. Maclean CJ, Baker HF, Ridley RM, Mori H. Naturally occurring and experimentally induced beta-amyloid deposits in the brains of marmosets (Callithrix jacchus). J Neural Transm 2000; 107:799-814; PMID:11005545; http://dx.doi.org/10.1007/s007020070060.
48. Walker LC, Levine H, 3rd, Mattson MP, Jucker M. Inducible proteopathies. Trends Neurosci 2006; 29:438-43; PMID:16806508; http://dx.doi.org/10.1016/j. tins.2006.06.010.
49. Aguzzi A. Cell biology: Beyond the prion principle. Nature 2009; 459:924-5; PMID:19536253; http://dx.doi.org/10.1038/459924a.
50. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, et al. Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 2006; 313:1781-4; PMID:16990547; http://dx.doi.org/10. 1126/science. 1131864.
51. Eisele YS, Bolmont T, Heikenwalder M, Langer F, Jacobson LH, Yan ZX, et al. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc Natl Acad Sci USA 2009; 106:12926-31; PMID:19622727; http://dx.doi.org/10.1073/pnas.0903200106.
52. Eisele YS, Obermüller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H, et al. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 2010; 330:980-2; PMID:20966215; http://dx.doi.org/10.1126/science. 1194516.
53. Caughey B, Baron GS, Chesebro B, Jeffrey M. Getting a grip on prions: oligomers, amyloids and pathological membrane interactions. Annu Rev Biochem 2009; 78:177-204; PMID:19231987; http://dx.doi.org/10.1146/annurev.biochem.78. 082907.145410.
54. Morales R, Duran-Aniotz C, Castilla J, Estrada LD, Soto C. De novo induction of amyloid-β deposition in vivo. [Epub ahead of print]. Mol Psychiatry 2011; PMID:21968933; http://dx.doi.org/10.1038/mp.2011.120.
55. Schnabel J. Amyloid: little proteins, big clues. Nature 2011; 475:12-4; PMID:21760575; http://dx.doi.org/10.1038/475S12a.